Regulating GAGs: The Role of GRASLND (G386597)

Target Name: GRASLND

NCBI ID: G386597

GRASLND

Other Name(s): Glycosaminoglycan regulatory associated long non-coding RNA | RNF144A-AS1 | glycosaminoglycan regulatory associated long non-coding RNA

Regulating GAGs: The Role of GRASLND

Glycosaminoglycan (GAG) regulatory associated long non-coding RNA (lncRNA) is a non-coding RNA molecule that plays a crucial role in regulating the activity of GAGs, which are a type of extracellular matrix (ECM) protein. GAGs are involved in various physiological processes in the cell, including cell signaling, tissue repair, and inflammation. They are also involved in diseases such as cancer, neurodegenerative diseases, and autoimmune diseases. As a result, targeting GAGs has been identified as a promising strategy for developing new drugs and biomarkers.

GRASLND is a specific lncRNA that is involved in the regulation of GAGs. It was first identified using RNA sequencing (RNA-seq) data and has since been shown to play a role in regulating the activity of various GAGs. GRASLND is expressed in various tissues and cells, including heart, liver, kidney, and brain, and has been shown to be involved in the regulation of GAG-related signaling pathways.

GRASLND has been shown to regulate the activity of several GAGs, including heparan sulfate proteoglycan (HSPG), which is a key component of the extracellular matrix and is involved in various physiological processes, including cell signaling and tissue repair. HSPG is known to play a role in diseases such as cancer, neurodegenerative diseases, and autoimmune diseases. By regulating HSPG activity, GRASLND may be involved in the development and progression of these diseases.

GRASLND has also been shown to regulate the activity of another GAG, called decorin. Decorin is a GAG that is involved in the regulation of cell migration and the formation of tight junctions, which are responsible for maintaining tissue structure and barriers. Decorin is known to play a role in diseases such as cancer, and targeting GRASLND may be a potential strategy for treating cancer.

GRASLND has also been shown to regulate the activity of a third GAG, called heparan triacetic acid (HTA). HTA is a GAG that is involved in the regulation of cell adhesion and the formation of tight junctions. HTA is known to play a role in diseases such as neurodegenerative diseases, and targeting GRASLND may be a potential strategy for treating these diseases.

In conclusion, GRASLND is a lncRNA that is involved in the regulation of GAGs, which are important regulators of various physiological processes in the cell. The regulation of GAGs by GRASLND may be a potential drug target or biomarker for a variety of diseases. Further research is needed to fully understand the role of GRASLND in regulating GAGs and to develop new treatments based on this information.

Protein Name: Glycosaminoglycan Regulatory Associated Long Non-coding RNA

The "GRASLND Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GRASLND comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets